2018 Fourth quarter stock market review
Interviewee/Contributor
William Ellington
Organisation
MedNous
Finance
Light on the horizon for Swedish biopharma
Interviewee/Contributor
Søren Tulstrup
Organisation
Hansa Medical AB
Altheia Science Srl: Italian biotech raises $11 mln for autoimmunity
Interviewee/Contributor
MedNous financing article
Organisation
Altheia Science Srl
Pharma slow to adopt SE incorporation
Interviewee/Contributor
William Ellington
Organisation
MedNous
The case for optimism for Europe's biotech sector
Interviewee/Contributor
Robin Davison
Organisation
New Science Global Healthcare Fund
European biotech searches for growth capital
Interviewee/Contributor
Eric Castaldi
Organisation
Argenx NV
Versant Ventures eyes start-ups in Europe
Interviewee/Contributor
Bradley Bolzon
Organisation
Versant Ventures
JP Morgan forum ends on a positive note
Interviewee/Contributor
Robin Davison
Organisation
New Science Global Healthcare Fund
Cheap capital gives rise to integrated pharma R&D
Interviewee/Contributor
John Rountree
Organisation
Novasecta Ltd
New risk capital for European companies
Interviewee/Contributor
Victoria English
Organisation
MedNous